Martin Scherer

Last updated
Prof. Martin Scherer Prof Martin Scherer.jpg
Prof. Martin Scherer

Martin Scherer (* born 27 July 1972 in Marburg) is a German university professor and specialist for general practice and primary care. He is director of the Department of General practice and Primary care and head of the Division of Primary Medical Care at the University Medical Center Hamburg-Eppendorf. [1] Since 2015 he is vice president of the German College of General Practitioners and Family Physicians (DEGAM) and since 2006 speaker of the Clinical Guidelines Committee. [2]

Contents

Biography

From 1993 until 1999 Scherer studied medicine in Marburg, Vienna and Paris. After he had finished his specialist training in general medicine in 2004, Scherer was research assistant in the division of general medicine of the University hospital Göttingen, from 2006 on as senior physician. In 2009 Scherer was appointed for the professorship health care research and became Deputy Director of the Institute for Social Medicine of the University of Lübeck. [3] Also in 2009 Scherer was founding member and Deputy Speaker of the academical Center for population medicine and health care research. Since 2012 Scherer has been director of the department of Primary Medical Care and head of the division of general medicine at the University Medical Center Hamburg-Eppendorff. [1] Furthermore, he is editor of the Hamburger Ärzteblatt. [4]

Scientific contribution

One of Scherer's scientific focus is to further develop methods in Health care research. Goal is to develop indicators which can be used to measure quality in health care provision. [5] Furthermore, Scherer is working on systematic surveys and meta-analyses. Through randomized controlled trials high levels of medical evidence are developed to trace the effectiveness of medical and diagnostic measures. [6] As a speaker of DEGAM, Scherer is dealing with the development of guidelines. Another focus of Scherer is multimorbidity. [7] [8] [9] Scherer is Co-Principal Investigator in several studies. In the MultiCare Claims Study, which is supported by the Federal Ministry of Education and Research (Germany), Scherer and Hendrik van den Bussche are investigating whether single illnesses and their interaction are relevant in terms of multimorbidity or whether it is rather the subjective consequences for patients. Together with Wolfgang Maier and Steffi Riedel-Heller, he is carrying out the AgeCoDe-Study about dementia. [10] [11] Scherer is Principal Investigator of the RECODE-study on heart failure. Furthermore, he is working on a guideline which aims to contribute to avoidance of over-, under provision in health care.

Memberships in scientific organisations

Scherer is member of various scientific organizations.

Publications

Related Research Articles

Evidence-based medicine (EBM) is "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients." The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management. The term was originally used to describe an approach to teaching the practice of medicine and improving decisions by individual physicians about individual patients.

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is the general name for a decline in cognitive abilities that impacts a person's ability to perform everyday activities. This typically involves problems with memory, thinking, and behavior. Aside from memory impairment and a disruption in thought patterns, the most common symptoms include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, caregivers, and on social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than what is caused by normal aging.

In medicine, comorbidity—from Latin morbus ("sickness"), co ("together"), -ity —is the presence of one or more additional conditions often co-occurring with a primary condition. Comorbidity describes the effect of all other conditions an individual patient might have other than the primary condition of interest, and can be physiological or psychological. In the context of mental health, comorbidity often refers to disorders that are often coexistent with each other, such as depression and anxiety disorders. The concept of multimorbidity is related to comorbidity but presents a different meaning and approach.

The Physicians Committee for Responsible Medicine (PCRM) is a non-profit animal liberation research and advocacy organization based in Washington, D.C., which promotes a plant-based diet, preventive medicine, and alternatives to animal research, and encourages what it describes as "higher standards of ethics and effectiveness in research." Its tax filing shows its activities as "prevention of cruelty to animals."

<span class="mw-page-title-main">Polypharmacy</span> Use of five or more medications daily

Polypharmacy (polypragmasia) is an umbrella term to describe the simultaneous use of multiple medicines by a patient for their conditions. The term polypharmacy is often defined as regularly taking five or more medicines but there is no standard definition and the term has also been used in the context of when a person is prescribed 2 or more medications at the same time. Polypharmacy may be the consequence of having multiple long-term conditions, also known as multimorbidity and is more common in people who are older. In some cases, an excessive number of medications at the same time is worrisome, especially for people who are older with many chronic health conditions, because this increases the risk of an adverse event in that population. In many cases, polypharmacy cannot be avoided, but 'appropriate polypharmacy' practices are encouraged to decrease the risk of adverse effects. Appropriate polypharmacy is defined as the practice of prescribing for a person who has multiple conditions or complex health needs by ensuring that medications prescribed are optimized and follow 'best evidence' practices.

A medical writer, also referred to as medical communicator, is a person who applies the principles of clinical research in developing clinical trial documents that effectively and clearly describe research results, product use, and other medical information. The medical writer develops any of the five modules of the Common Technical Document. The medical writers also ensure that their documents comply with regulatory, journal, or other guidelines in terms of content, format, and structure.

Multimorbidity, also known as multiple long-term conditions (MLTC), means living with two or more chronic illnesses. For example, a person could have diabetes, heart disease and depression at the same time. Multimorbidity can have a significant impact on people's health and wellbeing. It also poses a complex challenge to healthcare systems which are traditionally focused on individual diseases. Multiple long-term conditions can affect people of any age, but they are more common in older age, affecting more than half of people over 65 years old.

<span class="mw-page-title-main">German Agency for Quality in Medicine</span>

The German Agency for Quality in Medicine (AEZQ) - in German "Ärztliches Zentrum für Qualität in der Medizin (ÄZQ)", established in 1995 and located in Berlin, co-ordinates healthcare quality programmes with special focus on evidence-based medicine, medical guidelines, patient empowerment, patient safety programs, and quality management.

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen is a bilingual German and English language peer-reviewed medical journal published by Elsevier Germany. It was established in 1904 as the Zeitschrift für ärztliche Fortbildung by Ernst von Bergmann. ZEFQ is the organ of various organisations working in the fields of evidence-based medicine, patient empowerment, patient safety, and quality management in healthcare:. Among these are:

<span class="mw-page-title-main">Günter Ollenschläger</span>

Günter Ollenschläger is a German physician, medical editor, and á former professor of internal medicine and clinical decision making at the University of Cologne, Faculty of Medicine.

Tia Powell is an American psychiatrist and bioethicist. She is Director of the Montefiore-Einstein Center for Bioethics and of the Einstein Cardozo Master of Science in Bioethics Program, as well as a Professor of Clinical Epidemiology and Clinical Psychiatry at the Albert Einstein College of Medicine in The Bronx, New York. She holds the Trachtenberg Chair in Bioethics and is Professor of Epidemiology, Division of Bioethics, and Psychiatry. She was director of Clinical Ethics at Columbia-Presbyterian Hospital in New York City from 1992-1998, and executive director of the New York State Task Force on Life and the Law from 2004-2008.

Shared decision-making in medicine (SDM) is a process in which both the patient and physician contribute to the medical decision-making process and agree on treatment decisions. Health care providers explain treatments and alternatives to patients and help them choose the treatment option that best aligns with their preferences as well as their unique cultural and personal beliefs.

<span class="mw-page-title-main">José María Valderas Martínez</span>

Professor José María Valderas Martínez is an Academic General Practitioner and health services researcher.

<span class="mw-page-title-main">Andreas Spengler</span> German psychiatrist and researcher (born 1947)

Andreas Spengler is a German psychiatrist and researcher who conducted through 1974 and 1975 a well-known sociological study on sadomasochism in men at the Institute for Sexual Research in the University Hospital Eppendorf in Hamburg, Germany.

<span class="mw-page-title-main">Alexander Kapp (dermatologist and allergist)</span> German dermatologist and medical professor (born 1955)

Alexander Kapp is a German dermatologist and allergist. He was chairman and medical director of the department of dermatology and allergy at the Hannover Medical School until his retirement in 2022. He is known for his work in the field of pathophysiology of inflammatory skin diseases, his research on neuro-immunological interactions in allergic inflammation and on the role of eosinophilic granulocytes in allergy and dermatology.

Comprehensive geriatric assessment (CGA) is a process used by healthcare practitioners to assess the status of people who are frail and older in order to optimize their subsequent management. These people often have complex, multiple and interdependent problems (multimorbidity) which make their care more challenging than in younger people, or those with just one medical problem. CGA is the core work of specialists in the care of older people, although many other health care practitioners either have not heard of it, or are not aware of what it actually is. It is also called "multidimensional geriatric assessment."

The Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself.

The College of Health and Medicine is a college of the University of Tasmania that incorporates the School of Medicine, School of Health Sciences, Wicking Centre and Menzies Institute for Medical Research. The College incorporates medicine, pharmacy, psychology, paramedicine, nursing, laboratory medicine, allied health sciences and rural health into its curricula and research.

Goal-oriented health care, also known as goal-directed health care, goal-oriented medical care, and patient priorities care, is a form of health care delivery that is based on achieving individualized goals that are created through collaborative conversations between patients and providers in health care settings. It is a form of Patient Centered Care/Person-Centered Care as the goals are unique to the individual patient and direct the plan of care. This is in contrast to problem-oriented or disease-driven care where the focus is on correcting biological abnormalities. This philosophy of practice is become attractive in the medical community especially in primary care practices worldwide.

A non-pharmaceutical intervention or non-pharmacological intervention (NPI) is any type of health intervention which is not primarily based on medication. Some examples include exercise, sleep improvement, or dietary habits.

References

  1. 1 2 Martin Scherer at the University Medical Center Hamburg-Eppendorf
  2. "Martin Scherer, Spokesman for the Standing Committee of DEGAM". Archived from the original on 2017-11-10. Retrieved 2016-05-30.
  3. Appointments of professors, University of Lübeck
  4. Hamburger Ärzteblatt
  5. Herzberg H, Bernateck K, Welti F, Joos S, Pohontsch N, Blozik E, Scherer M. Patientenbeteiligung bei der Entwicklung von Qualitätsindikatoren am Beispiel der Nationalen VersorgungsLeitlinie Chronische Herzinsuffizienz - Eine qualitative Analyse kollektiver Sichtweisen. GESUNDHEITSWESEN. 2015
  6. Kötter T, da Costa B, Fässler M, Blozik E, Klaus L, Jüni P, Reichenbach S, Scherer M. Metamizol-assoziierte unerwünschte Arzneimittelwirkungen: Eine systematische Übersicht mit Metaanalyse.ZFA Z Allg Med. 2016;2016(92):72-78
  7. Löffler C, Altiner A, Streich W, Stolzenbach C, Fuchs A, Drewelow E, Hornung A, Feldmeier G, van den Bussche H, Kaduszkiewicz H. Multimorbidität aus Hausarzt- und Patientensicht. Z GERONTOL GERIATR. 2015
  8. von dem Knesebeck O, Scherer M, Bussche van den H, Schäfer I. Zusammenhang von sozialem Status und Multimorbidität. Hamburger Ärzteblatt. 2015;69(6):12-15
  9. Hansen H, Pohontsch N, Bussche van den H, Scherer M, Schäfer I. Reasons for disagreement regarding illnesses between older patients with multimorbidity and their GPs - a qualitative study. BMC FAM PRACT. 2015;16(1):68
  10. Roehr S, Luck T, Heser K, Fuchs A, Ernst A, Wiese B, Werle J, Bickel H, Brettschneider C, Koppara A, Pentzek M, Lange C, Prokein J, Weyerer S, Mösch E, König H, Maier W, Scherer M, Jessen F, Riedel-Heller S. Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly - Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe).PLOS ONE. 2016;11(1):e0147050.
  11. Heser K, Wagner M, Wiese B, Prokein J, Ernst A, König HH, Brettschneider C, Riedel-Heller SG, Luppa M, Weyerer S, Eifflaender-Gorfer S, Bickel H, Mösch E, Pentzek M, Fuchs A, Maier W, Scherer M, Eisele M, AgeCoDe Study Group. Associations between Dementia Outcomes and Depressive Symptoms, Leisure Activities, and Social Support. In: Dementia and Geriatric Cognitive Disorders extra, Band 4, Nr. 3, 2015; 481-93
  12. AQUA- Institute on Applied Quality Improvement and Research in Healthcare
  13. Versorgungsatlas of the Central Research Institute of Ambulatory Health Care